Paclitaxel- Versus Sirolimus-Eluting Stents for Unprotected Left Main Coronary Artery Disease

Journal of the American College of Cardiology

Volumn 53, Issue 19, 2009, Pages 1760-1768

  Mehilli, Julinda ^a   Kastrati, Adnan ^a   Byrne, Robert A ^a   Bruskina, Olga ^a   Iijima, Raisuke ^a   Schulz, Stefanie ^a   Pache, Jürgen ^a   Seyfarth, Melchior ^a   Maßberg, Steffen ^a   Laugwitz, Karl Ludwig ^b   Dirschinger, Josef ^b   Schömig, Albert ^a,b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

coronary artery disease; drug eluting stents; left main coronary artery; paclitaxel; restenosis; sirolimus

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRULOG; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PACLITAXEL; RAPAMYCIN;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; FEMALE; FOLLOW UP; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; REVASCULARIZATION; RISK ASSESSMENT; RISK FACTOR; THROMBOSIS; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CONFIDENCE INTERVALS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; MALE; MYOCARDIAL INFARCTION; PACLITAXEL; PLATELET AGGREGATION INHIBITORS; RISK; SIROLIMUS; TICLOPIDINE; TUBULIN MODULATORS;

EID: 65349105626     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.01.035     Document Type: Article

References (37)

1. Stone G.W., Moses J.W., and Leon M.B. Left main drug-eluting stents: natural progression or a bridge too far?. J Am Coll Cardiol 50 (2007) 498-500
2. Hlatky M.A., and Bravata D.M. Stents or surgery?. New data on the comparative outcomes of percutaneous coronary intervention and coronary artery bypass graft surgery. Circulation 118 (2008) 325-327
3. Bravata D.M., Gienger A.L., McDonald K.M., et al. Systematic review: the comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery. Ann Intern Med 147 (2007) 703-716
4. Buszman P.E., Kiesz S.R., Bochenek A., et al. Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization. J Am Coll Cardiol 51 (2008) 538-545
5. Dibra A., Kastrati A., Alfonso F., et al. Effectiveness of drug-eluting stents in patients with bare-metal in-stent restenosis: meta-analysis of randomized trials. J Am Coll Cardiol 49 (2007) 616-623
6. Kastrati A., Dibra A., Spaulding C., et al. Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction. Eur Heart J 28 (2007) 2706-2713
7. Stettler C., Wandel S., Allemann S., et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 370 (2007) 937-948
8. Stone G.W., Ellis S.G., Cannon L., et al. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA 294 (2005) 1215-1223
9. Windecker S., Remondino A., Eberli F.R., et al. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Engl J Med 353 (2005) 653-662
10. Schömig A., Dibra A., Windecker S., et al. A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease. J Am Coll Cardiol 50 (2007) 1373-1380
11. Dibra A., Kastrati A., Mehilli J., et al. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. N Engl J Med 353 (2005) 663-670
12. Chieffo A., Morici N., Maisano F., et al. Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: a single-center experience. Circulation 113 (2006) 2542-2547
13. Seung K.B., Park D.W., Kim Y.H., et al. Stents versus coronary-artery bypass grafting for left main coronary artery disease. N Engl J Med 358 (2008) 1781-1792
14. Eagle K.A., Guyton R.A., Davidoff R., et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). J Am Coll Cardiol 44 (2004) e213-e310
15. Yeatman M., Caputo M., Ascione R., Ciulli F., and Angelini G.D. Off-pump coronary artery bypass surgery for critical left main stem disease: safety, efficacy and outcome. Eur J Cardiothorac Surg 19 (2001) 239-244
16. Jonsson A., Hammar N., Nordquist T., and Ivert T. Left main coronary artery stenosis no longer a risk factor for early and late death after coronary artery bypass surgery-an experience covering three decades. Eur J Cardiothorac Surg 30 (2006) 311-317
17. Parsonnet V., Dean D., and Bernstein A.D. A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease. Circulation 79 (1989) I3-I12
18. Michel P., Roques F., and Nashef S.A. Logistic or additive EuroSCORE for high-risk patients?. Eur J Cardiothorac Surg 23 (2003) 684-687 discussion 687.
19. Cutlip D.E., Windecker S., Mehran R., et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115 (2007) 2344-2351
20. Chieffo A., Stankovic G., Bonizzoni E., et al. Early and mid-term results of drug-eluting stent implantation in unprotected left main. Circulation 111 (2005) 791-795
21. Takaro T., Peduzzi P., Detre K.M., et al. Survival in subgroups of patients with left main coronary artery disease. Veterans Administration Cooperative Study of Surgery for Coronary Arterial Occlusive Disease. Circulation 66 (1982) 14-22
22. Yusuf S., Zucker D., Peduzzi P., et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 344 (1994) 563-570
23. Valgimigli M., Malagutti P., Rodriguez-Granillo G.A., et al. Distal left main coronary disease is a major predictor of outcome in patients undergoing percutaneous intervention in the drug-eluting stent era: an integrated clinical and angiographic analysis based on the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) and Taxus-Stent Evaluated At Rotterdam Cardiology Hospital (T-SEARCH) registries. J Am Coll Cardiol 47 (2006) 1530-1537
24. Biondi-Zoccai G.G., Sangiorgi G.M., Chieffo A., et al. Validation of predictors of intraprocedural stent thrombosis in the drug-eluting stent era. Am J Cardiol 95 (2005) 1466-1468
25. Chieffo A., Park S.J., Meliga E., et al. Late and very late stent thrombosis following drug-eluting stent implantation in unprotected left main coronary artery: a multicentre registry. Eur Heart J (2009) In press.
26. Beauford R.B., Saunders C.R., Lunceford T.A., et al. Multivessel off-pump revascularization in patients with significant left main coronary artery stenosis: early and midterm outcome analysis. J Card Surg 20 (2005) 112-118
27. d'Allonnes F.R., Corbineau H., Le Breton H., Leclercq C., Leguerrier A., and Daubert C. Isolated left main coronary artery stenosis: long term follow up in 106 patients after surgery. Heart 87 (2002) 544-548
28. Holm F., Lubanda J.C., Semrad M., et al. [Main clinical and surgical determinants of in-hospital mortality after surgical revascularization of left main coronary artery stenosis: 2 year retrospective study (1998-1999)]. J Mal Vasc 29 (2004) 89-93
29. Jones R.H. Percutaneous intervention vs. coronary-artery bypass grafting in left main coronary disease. N Engl J Med 358 (2008) 1851-1853
30. Rademacher W., Knape A., Schumm J., et al. Acute and long-term outcome of unprotected left main coronary angioplasty compared to the anticipated surgical risk. Interact Cardiovasc Thorac Surg 7 (2008) 871-877
31. Biondi-Zoccai G.G., Lotrionte M., Moretti C., et al. A collaborative systematic review and meta-analysis on 1278 patients undergoing percutaneous drug-eluting stenting for unprotected left main coronary artery disease. Am Heart J 155 (2008) 274-283
32. Moses J.W., Leon M.B., Popma J.J., et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
33. Erglis A., Narbute I., Kumsars I., et al. A randomized comparison of paclitaxel-eluting stents versus bare-metal stents for treatment of unprotected left main coronary artery stenosis. J Am Coll Cardiol 50 (2007) 491-497
34. Lee B.K., Hong M.K., Lee C.W., et al. Five-year outcomes after stenting of unprotected left main coronary artery stenosis in patients with normal left ventricular function. Int J Cardiol 115 (2007) 208-213
35. Kastrati A., Dibra A., Eberle S., et al. Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials. JAMA 294 (2005) 819-825
36. Mauri L., Orav E.J., O'Malley A.J., et al. Relationship of late loss in lumen diameter to coronary restenosis in sirolimus-eluting stents. Circulation 111 (2005) 321-327
37. Serruys P.W. The SYNergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) Study. ESC 2008. http://www.escardio.org/congresses/esc2008/congress-reports/Documents/GG TSPU-gg.dhm.mhn.de-10648-8694494-DAT/esc08-reports-hotline2-1691-serruys -syntax.pdf Accessed November 2008.